ADRB2 haplotype is associated with glucose tolerance and insulin sensitivity in obese postmenopausal women

Obesity

Volumn 19, Issue 2, 2011, Pages 396-401

  Prior, Steven J ^a,b   Goldberg, Andrew P ^a,b   Ryan, Alice S ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN;

ABDOMINAL FAT; ADRB2 GENE; ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; BODY COMPOSITION; BODY FAT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE TEST; FEMALE; GENE; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HAPLOTYPE; HOMOZYGOSITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OXYGEN CONSUMPTION; PHYSIOLOGY; POSTMENOPAUSE; RACE;

AGED; BLOOD GLUCOSE; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HAPLOTYPES; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; POSTMENOPAUSE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 79551492289     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.197     Document Type: Article

References (28)

1. Barbe P, Millet L, Galitzky J, Lafontan M, Berlan M. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol 1996;117:907-913.
2. Lacey RJ, Cable HC, James RF et al. Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of Langerhans. J Endocrinol 1993;138:555-563.
3. Lee AD, Hansen PA, Schluter J et al. Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle. Am J Physiol 1997;273:C1082-C1087. (Pubitemid 27422189)
4. Mulder AH, Tack CJ, Olthaar AJ et al. Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab 2005;289:E627-E633.
5. Brochu M, Starling RD, Tchernof A et al. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab 2000;85:2378-2384.
6. Cowie CC, Rust K F, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268.
7. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999;42:98-101.
8. Park HS, Shin ES, Lee JE. Genotypes and haplotypes of beta2-adrenergic receptor and parameters of the metabolic syndrome in Korean adolescents. Metab Clin Exp 2008;57:1064-1070.
9. Rooyen JM, Pretorius PJ, Britz M et al. Genetic polymorphisms of beta2-and beta3-adrenergic receptor genes associated with characteristics of the metabolic syndrome in black South African women. Exp Clin Endocrinol Diabetes 2008;116:236-240.
10. González Sánchez JL, Proenza AM, Martínez Larrad MT et al. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clin Endocrinol (Oxf) 2003;59:476-481.
11. Masuo K, Katsuya T, Fu Y et al. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals. Am J Hypertens 2005;18:1009-1014.
12. Gjesing A P, Andersen G, Burgdorf KS et al. Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Diabetologia 2007;50:563-568. (Pubitemid 46215499)
13. Pinelli M, Giacchetti M, Acquaviva F et al. Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. BMC Med Genet 2006;7:85.
14. Terra SG, McGorray S P, Wu R et al. Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int J Obes (Lond) 2005;29:746-754.
15. Lima JJ, Feng H, Duckworth L et al. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metab Clin Exp 2007;56:757-765.
16. Gjesing A P, Sparsø T, Borch-Johnsen K et al. No consistent effect of ADRB2 haplotypes on obesity, hypertension and quantitative traits of body fatness and blood pressure among 6,514 adult Danes. PLoS ONE 2009;4:e7206.
17. Prior SJ, Joseph LJ, Brandauer J et al. Reduction in midthigh low-density muscle with aerobic exercise training and weight loss impacts glucose tolerance in older men. J Clin Endocrinol Metab 2007;92:880-886.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007;30 Suppl 1:S42-S47.
19. Andres R, Swerdloff RS, Pozefsky T, Coleman D. Manual feedback technique for the control of blood glucose concentration. Automation in analytical chemistry (Technician Symposium). New York, Mediad, 1966, 489-491.
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
21. Ryan AS, Nicklas BJ, Berman DM. Aerobic exercise is necessary to improve glucose utilization with moderate weight loss in women. Obesity (Silver Spring) 2006;14:1064-1072.
22. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
24. Matsukawa T, Sugiyama Y, Watanabe T, Kobayashi F, Mano T. Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol 1998;275:R1600-R1604.
25. Large V, Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 1998;24:409-418.
26. Eriksson P, Dahlman I, Rydén M, Hoffstedt J, Arner P. Relationship between beta-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women. Int J Obes Relat Metab Disord 2004;28:185-190.
27. McCole SD, Shuldiner AR, Brown MD et al. Beta2- and beta3-adrenergic receptor polymorphisms and exercise hemodynamics in postmenopausal women. J Appl Physiol 2004;96:526-530.
28. Garovic VD, Joyner MJ, Dietz NM, Boerwinkle E, Turner ST. Beta(2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol (Lond) 2003;546:583-589.